EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations Between FGF8, FGF18, and FGFR4 Expression and Immune Checkpoint Markers PD-1 and PD-L1 in Adenocarcinoma of the Gastroesophageal Junction (AEG)

Gerd Jomrich, Winny Yan, Dagmar Kollmann, Ivan Kristo, Daniel Winkler, Hannah Puhr, Aysegül Ilhan-Mutlu, Marlene Hollenstein, Reza Asari, Christian Sebesta, Sebastian F. Schoppmann

Cancers · 15.11.2026 · 18 (22) · 3653

DOI: 10.3390/cancers18223653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 15.11.2026. Verfasst von Gerd Jomrich und 10 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adenocarcinoma of the esophagogastric junction (AEG) remains a highly lethal disease despite multimodal therapy. The interplay between fibroblast growth factor (FGF) signaling and immune-checkpoint regulation in AEG is poorly understood. This study investigated the associations between FGF8, FGF18, and FGFR4 expression and PD-1/PD-L1/PD-L2 expression.

Methods

In a cohort of 117 resected AEG cases, immunohistochemical expression of FGF8, FGF18, PD-1, PD-L1, and PD-L2 was analyzed. Associations were assessed using chi-square tests and Pearson correlation analyses. Combined FGF8–FGF18 expression groups and survival outcomes were evaluated using Kaplan–Meier analysis.

Results

The updated correlation analysis included 107 cases and identified a weak inverse association between FGF8 expression and PD-L1 expression in tumor cells (r = −0.175, p = 0.036). No statistically significant correlations were observed between FGF18 expression and the investigated immune-checkpoint markers. Clinically, FGF18 was associated with advanced pT stage (p < 0.001) and postoperative UICC classification (p = 0.005), while both FGF8 (p = 0.022) and FGF18 (p = 0.015) were associated with lymph node metastasis. In the combined FGF8–FGF18 analysis, PD-1-negative lymphocytes occurred exclusively in the low-FGF8/low-FGF18 group (p = 0.042). Kaplan–Meier analysis demonstrated significantly poorer survival in FGF8-high tumors (p < 0.001).

Conclusions

FGF8 was associated with poorer overall survival and showed a weak inverse association with PD-L1 expression in tumor cells. FGF18 was not significantly correlated with the investigated immune-checkpoint markers. The association between combined FGF8–FGF18 expression patterns and PD-1 positivity in lymphocytes warrants further investigation.

Zitieren

APA

Jomrich, G., Yan, W., Kollmann, D., Kristo, I., Winkler, D., Puhr, H., Ilhan-Mutlu, A., Hollenstein, M., Asari, R., Sebesta, C., & Schoppmann, S. F. (2026). Associations Between FGF8, FGF18, and FGFR4 Expression and Immune Checkpoint Markers PD-1 and PD-L1 in Adenocarcinoma of the Gastroesophageal Junction (AEG). Cancers, 18(22), 3653. https://doi.org/10.3390/cancers18223653

Vancouver

Jomrich G, Yan W, Kollmann D, Kristo I, Winkler D, Puhr H, et al. Associations Between FGF8, FGF18, and FGFR4 Expression and Immune Checkpoint Markers PD-1 and PD-L1 in Adenocarcinoma of the Gastroesophageal Junction (AEG). Cancers. 2026;18(22):3653. doi:10.3390/cancers18223653

BibTeX
@article{Jomrich2026,
  author = {Jomrich, Gerd and Yan, Winny and Kollmann, Dagmar and Kristo, Ivan and Winkler, Daniel and Puhr, Hannah and Ilhan-Mutlu, Aysegül and Hollenstein, Marlene and Asari, Reza and Sebesta, Christian and Schoppmann, Sebastian F.},
  title = {Associations Between FGF8, FGF18, and FGFR4 Expression and Immune Checkpoint Markers PD-1 and PD-L1 in Adenocarcinoma of the Gastroesophageal Junction (AEG)},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3653},
  doi = {10.3390/cancers18223653}
}
Kostenlos starten →